Boletín de AInvest
Titulares diarios de acciones y criptomonedas, gratis en tu bandeja de entrada
Anteris Technologies Global Corp. has completed a $90 million strategic investment from Medtronic and raised $320 million in gross proceeds to support the global pivotal PARADIGM trial and advance the company's TAVR technology. The investment will aid in the development and commercialization of cutting-edge medical devices to restore healthy heart function.
Titulares diarios de acciones y criptomonedas, gratis en tu bandeja de entrada
Comentarios
Aún no hay comentarios